GW Pharma (GWPH): Most Likely Outcome of AES Meeting is $10 Upside, But Smaller Chance for Downside Pressure - Morgan Stanley
Tweet Send to a Friend
Morgan Stanley analyst Andrew Berens weighed in on GW Pharma (NASDAQ: GWPH) ahead of data releases this weekend at the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
